Immunology

Making immunotherapy safe for AML

Acute myeloid leukemia (AML), the second most common leukemia in children, is hard to treat and has a five-year survival rate of just 65 to 70%, according to the American Cancer Society. While immunotherapies like monoclonal ...

Genetics

Research sheds new light on gene therapy for blood disorders

Research from experts at Michigan Medicine, the Children's Hospital of Philadelphia and Penn Medicine is breaking ground on new ways of treating blood disorders, such as sickle cell anemia, through gene therapy. The study ...

Cardiology

How preeclampsia accelerates aging in women

Preeclampsia—the life-threatening surge in blood pressure that strikes 1 in 25 pregnancies—is an enigmatic condition. Each year, it causes the deaths of more than 70,000 women worldwide. Because scientists do not know ...

Oncology & Cancer

Studying the impact of stem cell transplants

People with sickle cell disease who receive nonmyeloablative stem cell transplants are at greater risk for developing new tumors, according to a new study published in the Journal of Clinical Oncology.

page 21 from 40